Individual Patient Data Validation of the EAU Definitions of BCG Failure in Patients with Non–muscle-invasive Urothelial Carcinoma of the Bladder: An International Multicenter Retrospective Study
Authors:
- 20 May 2026
- journal article
- Published by Elsevier in European Urology Oncology
- Vol. 9 (4) , 868-882
Abstract
No abstract availableKeywords
Funding Information
- European Association of Urology
This publication has 12 references indexed in Scilit:
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines UpdateEuropean Urology, 2024
- International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder CancerEuropean Urology, 2022
- European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelEuropean Urology, 2021
- Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non–muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-GuérinEuropean Urology, 2020
- Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive DiseaseEuropean Urology, 2019
- Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO GuidelineJournal of Urology, 2017
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-GuérinEuropean Urology, 2016
- BCG-refractory vs. BCG-relapsing non–muscle-invasive bladder cancer: A prospective cohort outcomes studyUrologic Oncology: Seminars and Original Investigations, 2015
- The optimum timing of radical cystectomy for patients with recurrent high‐risk superficial bladder tumourBJU International, 2004
- Intravesical BCG in Patients with Carcinoma in situ of the Urinary Bladder: Long–Term Results of EORTC GU Group Phase II Protocol 30861European Urology, 2001